Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dr John Patterson joins board at Ferring

This article was originally published in Scrip

Executive Summary

Ferring Pharmaceuticals (Switzerland) has appointed Dr John Patterson as a new board member. From December 2004 through to his retirement on March 31st, Mr Patterson was executive director at AstraZeneca. Before that, he held a number of roles in business and portfolio development for Zeneca and AstraZeneca and had an R&D career spanning 18 years with ICI Pharmaceuticals.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts